OPSUMIT (Actelion Pharmaceuticals US, Inc.)
Welcome to the PulseAid listing for the OPSUMIT drug offered from Actelion Pharmaceuticals US, Inc.. This Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actelion Pharmaceuticals US, Inc. |
| NON-PROPRIETARY NAME: | macitentan |
| SUBSTANCE NAME: | MACITENTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-11-04 |
| END MARKETING DATE: | 0000-00-00 |
OPSUMIT HUMAN PRESCRIPTION DRUG Details:
| Item Description | OPSUMIT from Actelion Pharmaceuticals US, Inc. |
| LABELER NAME: | Actelion Pharmaceuticals US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2013-11-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66215-501_be878637-a2c5-42ea-9924-fc868d1f1323 |
| PRODUCT NDC: | 66215-501 |
| APPLICATION NUMBER: | NDA204410 |
Other MACITENTAN Pharmaceutical Manufacturers / Labelers:
